drugset / Trial / NCT03020134
Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the Pharmacokinetics and safety of Ravidasvir in Combination with Ritonavir-boosted Danoprevir in Single and Multiple doses in Healthy Participants
Timeline
- Start
- 2016-07-15
- Primary completion
- 2016-08-22
- Completion
- 2016-08-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ravidasvir | Small molecule | 200 mg | Oral |
| Subject | Ritonavir | Other / unclassified | 100 mg | Oral |
| Subject | danoprevir | Small molecule | 100 mg | Oral |
Indications
No indication recorded.